圣达生物
(603079)
| 流通市值：23.31亿 | | | 总市值：23.31亿 |
| 流通股本：1.89亿 | | | 总股本：1.89亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 544,060,031.19 | 571,114,021.15 | 457,669,947.6 | 549,241,271.05 |
| 交易性金融资产 | 40,071,159.94 | 32,022,024.17 | 182,063,991.88 | 12,015,031.12 |
| 应收票据及应收账款 | 163,807,197.18 | 139,652,341.27 | 158,960,490.91 | 153,656,891.78 |
| 其中：应收票据 | 14,743,747.76 | 10,707,663.36 | 6,129,616.83 | 1,822,898 |
| 应收账款 | 149,063,449.42 | 128,944,677.91 | 152,830,874.08 | 151,833,993.78 |
| 应收款项融资 | 3,011,956.68 | 1,210,823.03 | 96,742.74 | 2,314,674.1 |
| 预付款项 | 4,915,431.37 | 4,040,461.51 | 4,203,142.85 | 5,426,999.12 |
| 其他应收款合计 | 20,948,318.71 | 420,702.78 | 374,897.18 | 355,234.66 |
| 存货 | 221,520,392.62 | 219,873,955.4 | 189,741,717.35 | 194,888,229.31 |
| 一年内到期的非流动资产 | 42,220,100 | 10,641,100 | 10,575,700 | 21,551,380.29 |
| 其他流动资产 | 7,685,167.88 | 7,436,535.96 | 6,722,998.98 | 21,245,135.5 |
| 流动资产合计 | 1,048,239,755.57 | 986,411,965.27 | 1,010,409,629.49 | 960,694,846.93 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 10,700,000 | 10,700,000 | 10,700,000 | 10,700,000 |
| 固定资产 | 879,323,933.46 | 634,957,922.82 | 461,287,969.07 | 459,573,253.69 |
| 在建工程 | 99,521,746.76 | 284,452,015.33 | 432,842,842.82 | 426,016,142.42 |
| 使用权资产 | 606,819.97 | 302,933.33 | 540,296.28 | 777,659.19 |
| 无形资产 | 201,288,739.37 | 221,247,207.27 | 222,944,435.33 | 224,827,743.66 |
| 商誉 | 10,909,393.98 | 10,909,393.98 | 10,909,393.98 | 10,909,393.98 |
| 长期待摊费用 | 981,753.68 | 1,121,980.93 | 1,947,238.14 | 3,103,026.41 |
| 递延所得税资产 | 6,492,726.16 | 6,759,142.47 | 7,005,908.27 | 225,066.68 |
| 其他非流动资产 | 9,180,457.88 | 35,652,336.64 | 39,962,240.3 | 49,444,514 |
| 非流动资产合计 | 1,219,005,571.26 | 1,206,102,932.77 | 1,188,140,324.19 | 1,185,576,800.03 |
| 资产总计 | 2,267,245,326.83 | 2,192,514,898.04 | 2,198,549,953.68 | 2,146,271,646.96 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 233,009,085.83 | 169,594,115.86 | 182,180,014.95 | 172,089,161.93 |
| 其中：应付票据 | 87,735,006.01 | 84,732,032.39 | 84,551,947.57 | 92,333,536.9 |
| 应付账款 | 145,274,079.82 | 84,862,083.47 | 97,628,067.38 | 79,755,625.03 |
| 合同负债 | 2,886,953.59 | 5,987,824.9 | 4,493,097 | 5,544,024.24 |
| 应付职工薪酬 | 18,268,273.07 | 13,659,886.37 | 27,878,350.11 | 19,777,492.67 |
| 应交税费 | 9,092,374.45 | 8,035,776.26 | 16,172,156.26 | 18,413,550.5 |
| 其他应付款合计 | 13,081,224.18 | 4,522,550.66 | 4,516,951.46 | 1,390,848.01 |
| 应付股利 | 8,833,524.9 | - | - | - |
| 一年内到期的非流动负债 | 7,647,607.02 | 4,042,544.45 | 6,320,642.94 | 476,596.33 |
| 其他流动负债 | 10,757,108.05 | 4,624,411.62 | 5,138,546.89 | 399,241.7 |
| 流动负债合计 | 294,742,626.19 | 210,467,110.12 | 246,699,759.61 | 218,090,915.38 |
| 非流动负债: | | | | |
| 长期借款 | 330,516,104.33 | 330,710,218.74 | 317,745,226.67 | 305,500,000 |
| 租赁负债 | 181,570.66 | - | - | - |
| 预计负债 | 8,100,000 | 8,100,000 | 8,100,000 | 8,100,000 |
| 递延收益 | 8,229,183.35 | 8,265,401 | 6,775,987.01 | 7,039,819.7 |
| 递延所得税负债 | 3,786,939.1 | 4,429,319.85 | 4,428,795.26 | 3,416,175.27 |
| 非流动负债合计 | 350,813,797.44 | 351,504,939.59 | 337,050,008.94 | 324,055,994.97 |
| 负债合计 | 645,556,423.63 | 561,972,049.71 | 583,749,768.55 | 542,146,910.35 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 189,029,624 | 189,029,624 | 189,029,624 | 189,029,624 |
| 资本公积 | 912,898,961.76 | 912,169,678.38 | 911,962,408.38 | 912,776,808.74 |
| 减:库存股 | 21,128,075.81 | 21,128,075.81 | 21,128,075.81 | 22,080,656.17 |
| 专项储备 | 174,301.75 | 221,660.63 | - | - |
| 盈余公积 | 59,808,576.3 | 59,808,576.3 | 59,808,576.3 | 58,567,589.69 |
| 未分配利润 | 446,660,178.41 | 458,051,045.22 | 444,876,356.25 | 437,300,189.01 |
| 归属于母公司股东权益合计 | 1,587,443,566.41 | 1,598,152,508.72 | 1,584,548,889.12 | 1,575,593,555.27 |
| 少数股东权益 | 34,245,336.79 | 32,390,339.61 | 30,251,296.01 | 28,531,181.34 |
| 股东权益合计 | 1,621,688,903.2 | 1,630,542,848.33 | 1,614,800,185.13 | 1,604,124,736.61 |
| 负债和股东权益合计 | 2,267,245,326.83 | 2,192,514,898.04 | 2,198,549,953.68 | 2,146,271,646.96 |
| 公告日期 | 2026-08-28 | 2026-04-27 | 2026-04-27 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |